Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ocumension Therapeutics (1477 HK)
Watchlist
34
Analysis
Health Care
•
China
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shenyang Xingqi Pharmaceutical
•
17 Mar 2024 19:50
China Healthcare Weekly (Mar.15)- New Policy of Innovative Drug, TCM Formula Granules, Xingqi Pharma
New policy of innovative drug is a big deal. We've reasons to start being optimistic.The market pattern of TCM formula granules will face...
Xinyao (Criss) Wang
Follow
342 Views
Share
bullish
•
Shenyang Xingqi Pharmaceutical
•
28 Oct 2024 01:30
China Healthcare Weekly (Oct.27)-10th National VBP, Revenue Scale Is the Only Moat, Xingqi’s Outlook
10th national VBP will impact big pharma like Kelun/Fosun/CSPC.Revenue scale is the only moat for pharma company.Xingqi's 24Q3 results may be...
Xinyao (Criss) Wang
Follow
257 Views
Share
bullish
•
Quantitative Analysis
•
15 Sep 2024 10:05
Hong Kong Connect Flows (Sep 13th): $1.5bn Inflows into Baba Post Inclusion
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, CCB, ICBC, Kuaishou Technology, Tencent,...
Ke Yan, CFA, FRM
Follow
359 Views
Share
bullish
•
Quantitative Analysis
•
01 Sep 2024 10:05
Hong Kong Connect Flows (Aug 30th): Tencent, Xiaomi Corporation
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), Xiaomi Corporation (1810 HK).
Ke Yan, CFA, FRM
Follow
312 Views
Share
bullish
•
Quantitative Analysis
•
25 Aug 2024 10:05
Hong Kong Connect Flows (Aug 23rd): Tencent, China Mobile
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), China Mobile (941 HK).
Ke Yan, CFA, FRM
Follow
299 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x